Genetic Effects on Dopamine Response to an Opiate

NCT01878006 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

NIH

Sponsor class

Conditions

Polymorphism-Genetic
Pain
Addiction

Interventions

DRUG: Morphine
DRUG: Placebo

Sponsor

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Collaborators

[object Object]